About Veripad
Veripad is a company based in New York (United States) founded in 2014 by Bishoy Ghobryal and Da Wi Shin. It operates as a B2B. Veripad operates in a competitive market with competitors including TruTag Technologies, Meditect, RxAll, Sproxil and PharmaSecure, among others.
- Headquarter New York, United States
- Founders Bishoy Ghobryal, Da Wi Shin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$50 K (USD), Grant
Nov 03, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Veripad
Investors in Veripad
Veripad has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked |
Investor details for Veripad
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veripad
Investment portfolio details for Veripad
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Veripad
Detailed financials for Veripad
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Veripad Comparisons
Peer comparison for Veripad
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Veripad
Veripad operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TruTag Technologies, Meditect, RxAll, Sproxil and PharmaSecure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Anti-counterfeiting solutions are offered via microscopic edible barcodes for authentication.
|
|
| Locked | Locked | Locked |
Falsified medicines are tracked via AI and blockchain software.
|
|
| Locked | Locked | Locked |
Medicines are authenticated via AI and spectrometers for pharmacy procurement.
|
|
| Locked | Locked | Locked |
Mobile technology is deployed to authenticate products against counterfeits.
|
|
| Locked | Locked | Locked |
Medication authenticity is verified through SMS by PharmaSecure.
|
|
| Locked | Locked | Locked |
Chemical code tagging solutions are used for counterfeit detection.
|
Detailed competitors of Veripad
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Veripad
Complete news archive for Veripad
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veripad
Veripad was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Veripad is headquartered in New York, United States. It is registered at New York, New York, United States.
Bishoy Ghobryal is the current CEO of Veripad. They have also founded this company.
Veripad a digital tool for medication management tailored to healthcare providers, focusing on providing healthcare solutions, providing digital health services, medication management, and tools for providers. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Veripad's top competitors include TruTag Technologies, Meditect and RxAll.
Veripad has 1 investor. Key investors include MassChallenge.